Squarepoint’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $461K | Buy |
|
|||||
|
2025
Q2 | $200K | Sell |
|
|||||
|
2025
Q1 | $207K | Hold |
|
|||||
|
2024
Q4 | $254K | Sell |
|
|||||
|
2024
Q3 | $12.9M | Buy |
|
|||||
|
2024
Q2 | $288K | Buy |
|
|||||
|
2024
Q1 | $377K | Buy |
|
|||||
|
2023
Q4 | $329K | Sell |
|
|||||
|
2023
Q3 | $3.21M | Buy |
|
|||||
|
2023
Q2 | $3.36M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.06M | Sell |
|
|||||
|
2022
Q1 | $17.6M | Buy |
|
|||||
|
2021
Q4 | $4.92M | Buy |
|
|||||
|
2021
Q3 | $406K | Sell |
|
|||||
|
2021
Q2 | $10M | Buy |
|
|||||
|
2021
Q1 | $1.51M | Sell |
|
|||||
|
2020
Q4 | $12.1M | Buy |
|
|||||
|
2020
Q3 | $2.21M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $3.96M | Sell |
|
|||||
|
2019
Q3 | $5.26M | Sell |
|
|||||
|
2019
Q2 | $6.47M | Buy |
|
|||||
|
2019
Q1 | $2.89M | Sell |
|
|||||
|
2018
Q4 | $10.2M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $437K | Sell |
|
|||||
|
2017
Q4 | $1.45M | Buy |
|
|||||
|
2017
Q3 | $1.25M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1.37M | Buy |
|
|||||
|
2016
Q4 | $744K | Buy |
|
|||||
|
2016
Q3 | $404K | Sell |
|
|||||
|
2016
Q2 | $1.3M | Sell |
|
|||||
|
2016
Q1 | $2.21M | Buy |
|
|||||
|
2015
Q4 | $541K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $470K | Buy |
|